324 related articles for article (PubMed ID: 28099825)
21. High Prevalence of inhA Promoter Mutations among Patients with Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa.
Niehaus AJ; Mlisana K; Gandhi NR; Mathema B; Brust JC
PLoS One; 2015; 10(9):e0135003. PubMed ID: 26332235
[TBL] [Abstract][Full Text] [Related]
22. Household contact investigation of multidrug-resistant and extensively drug-resistant tuberculosis in a high HIV prevalence setting.
Vella V; Racalbuto V; Guerra R; Marra C; Moll A; Mhlanga Z; Maluleke M; Mhlope H; Margot B; Friedland G; Shah NS; Gandhi NR
Int J Tuberc Lung Dis; 2011 Sep; 15(9):1170-5, i. PubMed ID: 21943840
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms of first-line antimicrobial resistance in multi-drug and extensively drug resistant strains of Mycobacterium tuberculosis in KwaZulu-Natal, South Africa.
Dookie N; Sturm AW; Moodley P
BMC Infect Dis; 2016 Oct; 16(1):609. PubMed ID: 27784282
[TBL] [Abstract][Full Text] [Related]
24. Mutations in extensively drug-resistant Mycobacterium tuberculosis that do not code for known drug-resistance mechanisms.
Motiwala AS; Dai Y; Jones-López EC; Hwang SH; Lee JS; Cho SN; Via LE; Barry CE; Alland D
J Infect Dis; 2010 Mar; 201(6):881-8. PubMed ID: 20136412
[TBL] [Abstract][Full Text] [Related]
25. Population-level emergence of bedaquiline and clofazimine resistance-associated variants among patients with drug-resistant tuberculosis in southern Africa: a phenotypic and phylogenetic analysis.
Nimmo C; Millard J; van Dorp L; Brien K; Moodley S; Wolf A; Grant AD; Padayatchi N; Pym AS; Balloux F; O'Donnell M
Lancet Microbe; 2020 Aug; 1(4):e165-e174. PubMed ID: 32803174
[TBL] [Abstract][Full Text] [Related]
26. Drug-resistant tuberculosis. In South Africa, XDR TB and HIV prove a deadly combination.
Koenig R
Science; 2008 Feb; 319(5865):894-7. PubMed ID: 18276863
[No Abstract] [Full Text] [Related]
27. Whole-genome sequencing of clinical isolates from tuberculosis patients in India: real-world data indicates a high proportion of pre-XDR cases.
Bhanushali A; Atre S; Nair P; Thandaseery GA; Shah S; Kuruwa S; Zade A; Nikam C; Gomare M; Chatterjee A
Microbiol Spectr; 2024 May; 12(5):e0277023. PubMed ID: 38597637
[TBL] [Abstract][Full Text] [Related]
28. Evolving rifampicin and isoniazid mono-resistance in a high multidrug-resistant and extensively drug-resistant tuberculosis region: a retrospective data analysis.
Mvelase NR; Balakrishna Y; Lutchminarain K; Mlisana K
BMJ Open; 2019 Nov; 9(11):e031663. PubMed ID: 31699736
[TBL] [Abstract][Full Text] [Related]
29. Risk factors for mortality among MDR- and XDR-TB patients in a high HIV prevalence setting.
Gandhi NR; Andrews JR; Brust JC; Montreuil R; Weissman D; Heo M; Moll AP; Friedland GH; Shah NS
Int J Tuberc Lung Dis; 2012 Jan; 16(1):90-7. PubMed ID: 22236852
[TBL] [Abstract][Full Text] [Related]
30. Improved early results for patients with extensively drug-resistant tuberculosis and HIV in South Africa.
O'Donnell MR; Padayatchi N; Master I; Osburn G; Horsburgh CR
Int J Tuberc Lung Dis; 2009 Jul; 13(7):855-61. PubMed ID: 19555535
[TBL] [Abstract][Full Text] [Related]
31. High fluoroquinolone resistance proportions among multidrug-resistant tuberculosis driven by dominant L2 Mycobacterium tuberculosis clones in the Mumbai Metropolitan Region.
Dreyer V; Mandal A; Dev P; Merker M; Barilar I; Utpatel C; Nilgiriwala K; Rodrigues C; Crook DW; ; Rasigade JP; Wirth T; Mistry N; Niemann S
Genome Med; 2022 Aug; 14(1):95. PubMed ID: 35989319
[TBL] [Abstract][Full Text] [Related]
32. Drug-resistant tuberculosis transmission and resistance amplification within families.
Seddon JA; Warren RM; Enarson DA; Beyers N; Schaaf HS
Emerg Infect Dis; 2012 Aug; 18(8):1342-5. PubMed ID: 22840848
[TBL] [Abstract][Full Text] [Related]
33. Genotypic diversity of extensively drug-resistant tuberculosis (XDR-TB) in South Africa.
Mlambo CK; Warren RM; Poswa X; Victor TC; Duse AG; Marais E
Int J Tuberc Lung Dis; 2008 Jan; 12(1):99-104. PubMed ID: 18173885
[TBL] [Abstract][Full Text] [Related]
34. Prevalence, associated factors, outcomes and transmission of extensively drug-resistant tuberculosis among multidrug-resistant tuberculosis patients in São Paulo, Brazil: a cross-sectional study.
Gallo JF; Pinhata JMW; Simonsen V; Galesi VMN; Ferrazoli L; Oliveira RS
Clin Microbiol Infect; 2018 Aug; 24(8):889-895. PubMed ID: 29175351
[TBL] [Abstract][Full Text] [Related]
35. Emergence and treatment of multidrug resistant (MDR) and extensively drug-resistant (XDR) tuberculosis in South Africa.
Streicher EM; Müller B; Chihota V; Mlambo C; Tait M; Pillay M; Trollip A; Hoek KG; Sirgel FA; Gey van Pittius NC; van Helden PD; Victor TC; Warren RM
Infect Genet Evol; 2012 Jun; 12(4):686-94. PubMed ID: 21839855
[TBL] [Abstract][Full Text] [Related]
36. Transmission, distribution and drug resistance-conferring mutations of extensively drug-resistant tuberculosis in the Western Cape Province, South Africa.
Oostvogels S; Ley SD; Heupink TH; Dippenaar A; Streicher EM; De Vos E; Meehan CJ; Dheda K; Warren R; Van Rie A
Microb Genom; 2022 Apr; 8(4):. PubMed ID: 35471145
[TBL] [Abstract][Full Text] [Related]
37. Minimal diversity of drug-resistant Mycobacterium tuberculosis strains, South Africa.
Gandhi NR; Brust JC; Moodley P; Weissman D; Heo M; Ning Y; Moll AP; Friedland GH; Sturm AW; Shah NS
Emerg Infect Dis; 2014 Mar; 20(3):426-33. PubMed ID: 24565645
[TBL] [Abstract][Full Text] [Related]
38. Extensively drug-resistant tuberculosis: new strains, new challenges.
Banerjee R; Schecter GF; Flood J; Porco TC
Expert Rev Anti Infect Ther; 2008 Oct; 6(5):713-24. PubMed ID: 18847407
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of isoniazid resistance-conferring mutations associated with multidrug-resistant tuberculosis in Free State Province, South Africa.
Pitso L; Potgieter S; Van der Spoel van Dijk A
S Afr Med J; 2019 Aug; 109(9):659-664. PubMed ID: 31635590
[TBL] [Abstract][Full Text] [Related]
40. Extensively drug-resistant tuberculosis in the United States, 1993-2007.
Shah NS; Pratt R; Armstrong L; Robison V; Castro KG; Cegielski JP
JAMA; 2008 Nov; 300(18):2153-60. PubMed ID: 19001626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]